Item 1.01
|
Entry into a Material Definitive Agreement
|
Underwriting Agreement
On May 12, 2020, Q2 Holdings, Inc. (the “Company,” “we,” “us” or “our”) entered into an underwriting agreement (the “Underwriting Agreement”) with J.P. Morgan Securities LLC, Citigroup Global Markets Inc., Stifel, Nicolaus & Company, Incorporated and SunTrust Robinson Humphrey, Inc., acting as representatives of the several underwriters named therein (collectively, the “Underwriters”), relating to the public offering (the “Offering”) by the Company of 4,117,647 shares of its common stock (the “Firm Shares”). Pursuant to the Underwriting Agreement, the Company granted the Underwriters the right to purchase from the Company up to an additional 117,647 shares of its common stock, and certain selling stockholders granted the Underwriters the right to purchase an additional 500,000 shares of the Company’s common stock, in each case exercisable within a 30-day period (the “Option Shares” and together with the Firm Shares, the “Shares”) at the public offering price less the underwriting discounts and commissions. On May 13, 2020, the Underwriters exercised their option to purchase the Option Shares in full.
The Offering was made pursuant to an automatically effective shelf registration statement on Form S-3 that the Company filed with the Securities and Exchange Commission (the “SEC”) on June 4, 2019 (File No. 333-231947), as amended by Amendment No. 1 thereto, as filed with the SEC on May 11, 2020. A prospectus supplement relating to the Offering has been filed with the SEC.
On May 15, 2020, the Offering closed and the Company completed the sale and issuance of an aggregate of 4,235,294 shares of its common stock and the selling stockholders sold an additional 500,000 shares of the Company’s common stock. The Company received net proceeds from the Offering of approximately $310.3 million, after deducting the underwriting discounts and commissions and offering expenses payable by the Company. The Company did not receive any proceeds from the sale of the shares of common stock by the selling stockholders.
A copy of the Underwriting Agreement is attached as Exhibit 1.1 hereto and is incorporated herein by reference. The foregoing description of the Underwriting Agreement does not purport to be complete and is qualified in its entirety by reference to such exhibit.
The legal opinion, including the related consent, of DLA Piper LLP (US) relating to the legality of the Shares sold is filed as Exhibit 5.1 to this Current Report on Form 8-K and is incorporated herein and into the Registration Statement by reference.